Although the diagnosis and grading of hepatic neuroendocrine tumors can be achieved by pathological features and the ki-67 index, it is difficult to differentiate primary hepatic neuroendocrine carcinomas from metastases using pathological evidence alone. The gene discussed is PSME3; the disease is Hepatitis.